Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 120
Infectious Diseases Drugs 90
Endocrine and Metabolic Disorders Drugs 74
Central Nervous System Drugs 60
Genomics 59
Immune Disorders Drugs 57
Pharmaceuticals 44
Drug Discovery 42
Diabetes Drugs 42
Prostate Cancer Drugs 41
Vaccines 40
Biopharmaceuticals 37
Clinical Trials 35
Urological Disorders Drugs 35
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 30
Biotechnology 28
Musculoskeletal Disorders Drugs 28
Cardiovascular Drugs 27
Liver and Kidney Disorders Drugs 26
Leukemia Drugs 24
Immunosuppressive Drugs 23
Antibiotics 21
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Surgical Procedures 20
Stem Cells 19
Oncology 19
Analgesics 18
Optical 14
Urology and Nephrology 13
Lung Cancer Drugs 13
Infusions and Injectables 13
Diagnostics 13
Medical Devices 13
Bladder Cancer Drugs 12
Drug Delivery 12
Dermatology 11
Healthcare Services 9
Respiratory Drugs 9
Pharmaceutical Manufacturing 9
Therapeutic Area 8
Neurology 8
Pulmonary Medicine 7
Lymphoma Drugs 7
Hearing Aids and Implants 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Pharmaceutical Intermediates 6
Biomaterials 6
Needles and Syringes 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Pediatrics 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Skin Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Palliative Care 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anatomy 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,135 Results (Page 47 of 57)
- Relevance
  Sort by

Vasopressin Receptor Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

Pompe Disease - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7035EUR$7,950USD£6,129GBP

Red Biotechnology Market 2025-2029

 Report
August 2025
215 Pages
Global

From

€2212EUR$2,500USD£1,927GBP

Chronic Kidney Disease: Global Markets and Technologies Through 2023

 Report
April 2019
153 Pages
Global

From

€2434EUR$2,750USD£2,120GBP

MMR Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
104 Pages
Global

From

€3500EUR$4,237USD£3,156GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
102 Pages
Global

From

€3982EUR$4,500USD£3,469GBP

Cosmetic Surgery Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3973EUR$4,490USD£3,461GBP

Pompe Disease Drugs Market 2024-2028

 Report
January 2024
161 Pages
Global

From

€2212EUR$2,500USD£1,927GBP

Cholera Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

 Report
April 2023
114 Pages
Global

From

€4204EUR$4,750USD£3,662GBP

STAT Inhibitors - Pipeline Insight, 2025

 Clinical Trials
July 2025
80 Pages
Global

From

€1770EUR$2,000USD£1,542GBP

Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2032

 Drug Pipelines
June 2025
150 Pages
Global

From

€3319EUR$3,750USD£2,891GBP

Revenue Cycle Management Market Report and Forecast 2023-2031

 Report
May 2023
147 Pages
Global

From

€4380EUR$4,949USD£3,815GBP

Regenerative Medicine Market Analysis & Forecast to 2024-2034: Market By Product; By Application; By End-user; and By Region

 Report
March 2024
200 Pages
Global

From

€3673EUR$4,150USD£3,199GBP

11 Beta-Hydroxysteroid Dehydrogenase (11ßHSD) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

Aspergillosis - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1327EUR$1,500USD£1,156GBP

Guanylate Cyclase-Coupled Receptor Activators - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1106EUR$1,250USD£964GBP

Musculoskeletal Disorders Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
August 2024
113 Pages
Global

From

€3500EUR$4,237USD£3,156GBP

1,135 Results (Page 47 of 57)
- 1
- 45
- 46
- 47
- 48
- 49

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.